Volume 10, Issue 1 (Winter 2022)
PCP 2022, 10(1): 11-22 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Eftekari A, Bakhtiari M. Comparing the Effectiveness of Schema Therapy With Acceptance and Commitment Therapy on Cognitive Avoidance in Patients With Generalized Anxiety Disorder. PCP 2022; 10 (1) :11-22
URL: http://jpcp.uswr.ac.ir/article-1-587-en.html
URL: http://jpcp.uswr.ac.ir/article-1-587-en.html
1- Department of Clinical Psychology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Department of Clinical Psychology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ,maryam_bakhtiyari@sbmu.ac.ir
2- Department of Clinical Psychology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ,
Abstract: (3318 Views)
Objective: This study aimed to compare the effectiveness of schema therapy with acceptance and commitment therapy (ACT) using exposure techniques on cognitive avoidance in female patients with generalized anxiety disorder.
Methods: A total of 10 women with generalized anxiety disorder were selected through purposeful sampling with Structured Clinical Interview for DSM Disorders (SCID-5). To determine the absence of personality disorder, Millon’s clinical multiaxial inventory (MCMI-III) (Millon and Groosman, 2005) was used. Schema therapy was conducted for 20 weekly sessions and ACT with exposure techniques for 12 weeks and follow-up for 6 weeks. The cognitive avoidance questionnaire (CAQ) (Sexton and Douglas, 2004) was used as a pretest and posttest to follow up on the results. Analysis of variance with repeated measures was used to test the research hypotheses.
Results: The results showed that schema therapy is more effective than ACT in the subscales of thought suppression (F=12.80, P=0.037) and avoidance of threatening (F=25.61, P=0.015), but they have no significant statistical difference in other subscales and total score. Both treatments significantly reduced the total score of cognitive avoidance, but they lacked a statistically significant difference.
Conclusion: Schema therapy and ACT with exposure techniques are effective in reducing the severity of symptoms and improving cognitive avoidance in females with generalized anxiety disorder.
Methods: A total of 10 women with generalized anxiety disorder were selected through purposeful sampling with Structured Clinical Interview for DSM Disorders (SCID-5). To determine the absence of personality disorder, Millon’s clinical multiaxial inventory (MCMI-III) (Millon and Groosman, 2005) was used. Schema therapy was conducted for 20 weekly sessions and ACT with exposure techniques for 12 weeks and follow-up for 6 weeks. The cognitive avoidance questionnaire (CAQ) (Sexton and Douglas, 2004) was used as a pretest and posttest to follow up on the results. Analysis of variance with repeated measures was used to test the research hypotheses.
Results: The results showed that schema therapy is more effective than ACT in the subscales of thought suppression (F=12.80, P=0.037) and avoidance of threatening (F=25.61, P=0.015), but they have no significant statistical difference in other subscales and total score. Both treatments significantly reduced the total score of cognitive avoidance, but they lacked a statistically significant difference.
Conclusion: Schema therapy and ACT with exposure techniques are effective in reducing the severity of symptoms and improving cognitive avoidance in females with generalized anxiety disorder.
Type of Study: Original Research Article |
Subject:
Cognitive behavioral
Received: 2018/07/14 | Accepted: 2021/12/4 | Published: 2022/01/1
Received: 2018/07/14 | Accepted: 2021/12/4 | Published: 2022/01/1
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
